| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Common Stock | -Sell | -$431,265 | -738 | -4.67% | $584.37 | 15,069 | Feb 3, 2023 | Direct | F1 |
| transaction | TMO | Common Stock | -Sell | -$153,294 | -262 | -1.74% | $585.09 | 14,807 | Feb 3, 2023 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $583.93 to $584.685, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $584.83 to $585.37, inclusive. |
Exhibit List: Exhibit 24 - Confirming Statement